Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ALLR Allarity Therapeutics Inc

1,015

-0,025 (-2,40%)

24 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Allarity Therapeutics Charts.

News Allarity Therapeutics Inc

Form 8-K - Current report
Dienstag 19 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Montag 18 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 14 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights
Donnerstag 14 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 23 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib
Dienstag 22 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 11 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
Donnerstag 10 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 4 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program
Donnerstag 3 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 1 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Allarity Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen